Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

Radiochemical synthesis, automation, and in vivo biodistribution of 4-[18F] Fluorobenzyl-Harmine (F-18 FB-Harmine)

Aruna Korde, Sudha Garg, Holly Smith, Kimberly Black and Pradeep Garg
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 298;
Aruna Korde
1Wake Forest Univ. Medical Center, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudha Garg
1Wake Forest Univ. Medical Center, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holly Smith
1Wake Forest Univ. Medical Center, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly Black
1Wake Forest Univ. Medical Center, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pradeep Garg
1Wake Forest Univ. Medical Center, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

298

Objectives Previous efforts to develop PET imaging probes to study Monoamine oxidase (MAO) primarily focused on developing C-11 labeled compouds such as C-11 deprenyl, C-11 Harmine, and C-11 clorgyline. An F-18 labeled compound will allow for its use at sites without an on-site cyclotron. Herein, we report synthesis of a novel F-18 fluorobenzyl analogue of harmine and our preliminary results from biodistribution studies performed in normal rats.

Methods F-18 FB-Harmine was prepared by reacting 4-[18F]fluorobenzyl iodide (prepared as described earlier) with Harmine (1 eq) and NaH (1.3 eq) at 110°C for 10 min. The desired product was isolated using a semi-prep HPLC. The synthesis was controlled remotely through an automated PLC unit. Five rats were injected with 20 μCi F-18 FB-Harmine and were sacrificed 60 min post injection. Various tissues were excised, weighed, and counted for radioactivity.

Results The radiochemical synthesis was automated for reliability and safe handling. F-18 FB-Harmine was prepared in 28.8±4.5% RCY with a specific activity of >2000 mCi/μmole and in synthesis time of 150 min. The in vivo biodistribution studies show a rapid clearance of radioactivty primarily via urinary excretion.The F-18 uptake in liver, spleen, lungs, kidney, pancrease, adrenal glands, and muscle was 0.40±0.11, 0.12±0.02, 0.13±0.02, 0.35±0.06, 0.15±0.06, 0.08±0.04, and 0.04±0.01%ID/g tissue, respectively. Uptake in the brain was modest, providing brain to muscle ratio of 1.9±0.27 at 60 min. A low bone uptake (0.05±0.01%ID/g) demonstrated its resistance to in vivo defluorination.

Conclusions Herein, we report a novel F-18 labeled MAO probe i.e. F-18 FB-Harmine for PET imaging. The product was prepared in good RCY and high specific activity, using an automated process. The in vivo biodistribution studies show an overall low F-18 accumulation in most normal organs and a modest uptake in the brain. Additional studies are planned to further elucidate its uptake specificity and retention characteristics

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiochemical synthesis, automation, and in vivo biodistribution of 4-[18F] Fluorobenzyl-Harmine (F-18 FB-Harmine)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiochemical synthesis, automation, and in vivo biodistribution of 4-[18F] Fluorobenzyl-Harmine (F-18 FB-Harmine)
Aruna Korde, Sudha Garg, Holly Smith, Kimberly Black, Pradeep Garg
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 298;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiochemical synthesis, automation, and in vivo biodistribution of 4-[18F] Fluorobenzyl-Harmine (F-18 FB-Harmine)
Aruna Korde, Sudha Garg, Holly Smith, Kimberly Black, Pradeep Garg
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 298;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
  • Novel probes targeting urokinase plasminogen activator (uPA) for imaging metastatic potential
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

New Radiopharmaceuticals-Novel Probe Development III

  • [11C]Ro 31-7453 (MKC-1) as a new PET cancer imaging agent involving multiple targets
  • Synthesis and evaluation of radioiodinated exendin derivatives for the imaging of GLP-1 receptor expression in pancreatic islets
Show more New Radiopharmaceuticals-Novel Probe Development III

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire